Dr. Robert Glen

Biography

Robert Glen is an accomplished Professor of Computational Medicine at Imperial College London, appointed in 2014. He has a rich background in computational chemistry, X-ray crystallography, and organic synthesis, gaining his Ph.D. under the supervision of Prof. Peter Murray-Rust at the University of Stirling. His career includes significant contributions as a Senior Research Scientist at the Wellcome Foundation, where he led the development of computer-aided molecular design tools extensively used in the pharmaceutical industry. He co-invented Zomig, a drug that advanced to Phase-2 clinical development. Glen's expertise extends to designing drug discovery programs focused on obesity and sleep disorders, and he has played an instrumental role in establishing the Unilever Centre for Molecular Sciences Informatics at the University of Cambridge, boasting over 700 publications. Glen has actively engaged in Big Data projects, focusing on metabolomics and machine learning, while being closely associated with the National Phenome Centre and the Institute of Translational Medicine and Therapeutics. He has delivered lectures at prominent conferences and consultancy for large pharmaceutical companies, securing extensive grants over the past decade from various prominent funding bodies such as the Wellcome Trust and NHS. His current research involves AI and Machine Learning applications in drug discovery for cancer and cardiovascular diseases.

Research Interests

Experience

Awards